Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeUncategorizedOrthAlign Announces Clinical Milestone Having Performed 200,000 Joint Arthroplasty Cases Worldwide

OrthAlign Announces Clinical Milestone Having Performed 200,000 Joint Arthroplasty Cases Worldwide

OrthAlign, Inc., a privately held U.S.-based medical device and technology company providing orthopedic surgeons with advanced precision technologies, announced a clinical milestone of 200,000 OrthAlign-assisted joint replacement surgeries worldwide.

Indicated for total knee replacement, partial knee replacement, and total hip replacement, OrthAlign’s intuitive, handheld navigation technologies provide an accurate, cost-effective tool ideal for both the hospital and ASC environments.

OrthAlign delivers accurate, individualized alignment to any patient with a single-use, handheld smart tool that can be used across implant platforms and surgical philosophies. The user-friendly design and interface provide streamlined workflows to reduce OR times and support multiple ORs concurrently without the investment, equipment, or pre-operative imaging required by many computer-assisted surgical systems. The technology is optimized for the ASC with only one instrument tray, one navigation unit for all applications, and no storage requirements or service plans.

A steady cadence of updates and product launches have supported the exponential adoption and growth of OrthAlign technology. KneeAlign®, the company’s flagship application, provides tibial and femoral intra-operative navigation for total knee arthroplasty. UniAlign®, launched in early 2017, leveraged the clinical success of KneeAlign, and allows for a seamless transition between partial and total knee replacement. In 2018, HipAlign® became commercially available and currently supports real time abduction and anteversion measurements of the acetabular cup and assess intra-operative changes in leg length and offset for both lateral or supine based approaches.

“OrthAlign has given me accuracy and reproducibility,” said Dr. Rafael Sierra, Orthopedic Surgeon in Rochester, MN. “My first introduction to OrthAlign was a tough case with hardware in the femur, and I wanted to see if I could avoid taking the hardware out of a young patient. OrthAlign was the perfect instrument for that situation. After that experience, I was very excited about its use and expanded it into my other knee replacements. When performing anatomic alignment, it is very challenging, with manual instrumentation, to determine the exact degree of a slightly varus tibial cut. You want consistent precision, and that’s what OrthAlign gives me.”

“This is another great milestone for our organization that emphasizes the commitment of surgeons to our products,” said Eric Timko, Chairman and CEO of OrthAlign Inc. “This has been an exciting journey for OrthAlign and with the launch underway of our next generation flagship product, Lantern, we expect our strong momentum to continue. Technology in every room and in every case is the future; OrthAlign is the catalyst to make that happen. We’ve seen market-leading growth, quarter after quarter, because our surgeons love the simplicity and efficiency of the system, and they’re seeing great results. As the market continues to adopt technology and total joints move to the ASC, we are well positioned to drive these transitions and deliver clinically-proven technology that meets the operational and financial needs of all sites of service. Our future is bright, and we look forward to what’s ahead.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy